Editorial & Review Policy
Radiation Oncology AI Network is designed around a human-review-first publishing model. Automated discovery may identify candidate research or updates, but automated discovery alone does not authorize publication.
Source preference
Priority should be given to primary and authoritative sources, including peer-reviewed publications, official clinical-trial registries, government or intergovernmental resources, professional societies and official project repositories.
Verification
Editors should verify titles, authorship, dates, trial identifiers, organization links, claims and material status changes against the source before publication.
AI-assisted work
AI may assist discovery, organization, summarization or translation, but substantive medical and scientific content should receive appropriate human review before publication.
Conflicts and transparency
Material financial, institutional or authorship relationships relevant to submitted content should be disclosed when appropriate. Sponsored material, if introduced in the future, should be clearly labeled.
Translations
Translated medical content should be reviewed for terminology, meaning and context before publication. The English source may be treated as the reference version unless otherwise stated.